Kazakhstan vs Serbia: Death rate from cardiomyopathy, myocarditis and endocarditis

Kazakhstan
31.11 deaths per 100,000 people
in 2021
Serbia
82.2 deaths per 100,000 people
in 2021
Kazakhstan rank
4th
Serbia rank
1st

Death rate from cardiomyopathy, myocarditis and endocarditis over time

  • Kazakhstan
  • Serbia
050100150200020102021

How they compare

Serbia currently reports 82.2 deaths per 100,000 people against 31.11 deaths per 100,000 people in Kazakhstan, a difference of 51.09 deaths per 100,000 people.

That makes Serbia's figure about 2.6 times Kazakhstan's.

Across all 22 years both countries report, Serbia has been ahead every year.

Kazakhstan ranks 4th and Serbia ranks 1st of 194 countries.

Serbia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Kazakhstan Serbia Difference Ahead
2000s 31.32 deaths per 100,000 people 107.6 deaths per 100,000 people 76.28 deaths per 100,000 people Serbia
2010s 42.18 deaths per 100,000 people 86.75 deaths per 100,000 people 44.57 deaths per 100,000 people Serbia
2020s 33.09 deaths per 100,000 people 81.63 deaths per 100,000 people 48.54 deaths per 100,000 people Serbia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher death rate from cardiomyopathy, myocarditis and endocarditis, Kazakhstan or Serbia?
Serbia, at 82.2 deaths per 100,000 people against 31.11 deaths per 100,000 people in Kazakhstan as of 2021.
What is the difference in death rate from cardiomyopathy, myocarditis and endocarditis between Kazakhstan and Serbia?
51.09 deaths per 100,000 people, with Serbia ahead.
How many years of comparable data are there for Kazakhstan and Serbia?
22 years are reported by both, from 2000 to 2021.
How do Kazakhstan and Serbia rank globally for death rate from cardiomyopathy, myocarditis and endocarditis?
Kazakhstan ranks 4th and Serbia ranks 1st of 194 countries.
Where does this data come from?
World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cardiomyopathy, myocarditis and endocarditis. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Kazakhstan vs Serbia: Death rate from cardiomyopathy, myocarditis and endocarditis. Statizoid, drawing on World Health Organization (2024) – with major processing by Our World in Data. Retrieved 14 September 2026, from https://health.statizoid.com/compare/death-rate-from-cardiomyopathy-myocarditis-endocarditis-who-ghe-age-standardized/kazakhstan/serbia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/death-rate-from-cardiomyopathy-myocarditis-endocarditis-who-ghe-age-standardized/kazakhstan/serbia/">Kazakhstan vs Serbia: Death rate from cardiomyopathy, myocarditis and endocarditis</a> — Statizoid

About this data

Indicator
Death rate from cardiomyopathy, myocarditis and endocarditis
Unit
deaths per 100,000 people
Source
World Health Organization (2024) – with major processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
194 places, 4,268 data points, 2000–2021
Last refreshed

Estimated number of age-standardized deaths from cardiomyopathy, myocarditis, endocarditis in both sexes, per 100,000 people.